Financhill
Back

ALX Oncology Holdings Stock Predictions

ALX Oncology Holdings Stock Forecast

  • Is ALX Oncology Holdings Stock Undervalued?
    The current ALX Oncology Holdings [ALXO] share price is $1.41. The Score for ALXO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • ALXO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will ALX Oncology Holdings Stock Go Up Next Year?

Data Unavailable

ALX Oncology Holdings Stock Rating

Data Unavailable

ALX Oncology Holdings Stock Price History

Is ALXO stock going to rise?

  • The current trend is relatively stagnant and ALXO is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alxoncology.com

52-Week Data

52-Week High:
17.83
52-Week Low:
1.19

Prediction Charts

Market Cap:
74.37M
Price in USD:
1.41
Volume:
966.92K
Beta:
1.04

Technical Analysis

SMA50:
1.62
SMA100:
2.83
SMA200:
7.78
52-Wk Change:
-84.69%

Stock Predictions

  • Is ALX Oncology Holdings stock public?
    Yes, ALX Oncology Holdings is a publicly traded company.
  • What is the ALX Oncology Holdings stock quote today?
    The ALX Oncology Holdings stock price is 1.41 USD today.
  • How to buy ALX Oncology Holdings stock online?
    You can buy ALX Oncology Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 1.48 1.52 1.52 1.45
Nov-6 1.54 1.53 1.57 1.44
Nov-7 1.53 1.51 1.56 1.45
Nov-8 1.55 1.45 1.63 1.44
Nov-11 1.50 1.48 1.58 1.47
Nov-12 1.47 1.35 1.50 1.34
Nov-13 1.35 1.35 1.41 1.30
Nov-14 1.33 1.33 1.38 1.33
Nov-15 1.35 1.29 1.35 1.25
Nov-18 1.27 1.22 1.30 1.21
Nov-19 1.22 1.23 1.27 1.19
Nov-20 1.22 1.21 1.25 1.21
Nov-21 1.22 1.29 1.33 1.21
Nov-22 1.27 1.41 1.44 1.27

ALX Oncology Holdings Earnings

Data Unavailable

ALX Oncology Holdings Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and a decrease next year of $0.58 per share.

* ALX Oncology Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.